Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | 31.42M | $968.0M | 24.74% | -- | 2026-06-30 |
| BlackRock, Inc. | 16.42M | $506.0M | 12.93% | +1.19M | 2026-06-30 |
| State Street Corp | 6.03M | $185.0M | 4.75% | +616.6K | 2026-06-30 |
| Wellington Management Group LLP | 5.90M | $181.0M | 4.64% | -194.1K | 2026-06-30 |
| Montanova Capital, LLC | 4.78M | $147.0M | 3.76% | -254.6K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 4.48M | $137.0M | 3.52% | +203.5K | 2026-06-30 |
| FMR LLC | 4.05M | $124.0M | 3.19% | +2.88M | 2026-06-30 |
| Vanguard Capital Management LLC | 3.89M | $119.0M | 3.06% | +31.6K | 2026-06-30 |
| Citadel Advisors LLC | 3.16M | $97.0M | 2.49% | +1.74M | 2026-06-30 |
| Woodline Partners LP | 3.01M | $92.0M | 2.37% | -770.0K | 2026-06-30 |
